I am a Strategic Advisor to Genpax.  We are developing a game-changing analysis platform which will transform the world's ability to manage bacteriological infection across healthcare, food, enviroment and community acquired disease.
Whole Genome Sequencing (WGS) is the only technology that has the potential to unlock truly effective surveillance and infection-control systems. To date, however, no one has overcome the limitations of the WGS analysis, which is too slow, too costly, and too incomplete to be effectively used in real-life situations. Now, 25 years of research allow us to be the first to operationalise WGS analysis at the highest possible resolution, accurately and at scale.

https://www.genpax.co/